The question of whether IgA anti-B2GPI may have diagnostic value for APS was subsequently addressed by the “non-criteria” antiphospholipid task force during the 13th International Congress on Antiphospholipid Antibodies held in April 2010 in Galveston, Texas. This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.